摘要
目的:探讨莫西沙星与头孢哌酮钠舒巴坦钠联合治疗老年重症肺炎的效果。方法:选取老年重症肺炎患者88例,分为对照组(n=44)和观察组(n=44),对照组采用头孢哌酮钠舒巴坦钠进行治疗,观察组在对照组基础上加用莫西沙星进行治疗,比较两组治疗效果。结果:观察组治疗后治疗总有效率和病原菌清除率高于对照组,痰液颜色改变时间、体温恢复正常时间以及白细胞计数下降时间上均优于对照组,差异均具有统计学意义(P均<0.01)。结论:莫西沙星和头孢哌酮钠舒巴坦钠联合治疗老年重症肺炎的效果显著。
Objective： To investigate the effects of moxifloxacin combined with cefoperazone sulbactam on severe pneumonia. Methods： 88 cases of elderly patients with severe pneumonia were randomized into the control group（ n = 44） and observation group（ n = 44）. Patients in the control group were given cefoperazone sodium and sulbactam sodium for treatment,while patients in the observation group were treated with moxifloxacin on the basis of the treatment received by the control group. Then,the treatment effects were compared between the two groups. Results： After treatment,the total effective rate and the pathogen clearance rate in the observation group was higher than that of the control group,sputum color change time,recovery time of body temperature and white blood cell count down time were better than those of the control group,which were of statistical differences（ P〈0.01）. Conclusion： The combination treatment with moxifloxacin and cefoperazone sulbactam has gained better effect in the treatment of severe pneumonia.
出处
《华夏医学》
CAS
2017年第4期11-13,共3页
Acta Medicinae Sinica
关键词
重症肺炎
莫西沙星
头孢哌酮钠舒巴坦钠
severe pneumonia
moxifloxacin
cefoperazone sodium and sulbactam sodium
